Wells Fargo’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,143,828
Closed -$213M 7098
2019
Q3
$213M Buy
2,143,828
+99,411
+5% +$9.45M 0.06% 322
2019
Q2
$189M Sell
2,044,417
-17,737
-0.9% -$1.68M 0.05% 346
2019
Q1
$195M Sell
2,062,154
-1,581,843
-43% -$138M 0.06% 330
2018
Q4
$234M Sell
3,643,997
-781,094
-18% -$57.7M 0.08% 250
2018
Q3
$396M Sell
4,425,091
-4,880
-0.1% -$431K 0.11% 181
2018
Q2
$352M Sell
4,429,971
-1,251,013
-22% -$104M 0.1% 197
2018
Q1
$507M Buy
5,680,984
+499,288
+10% +$47.9M 0.15% 140
2017
Q4
$541M Sell
5,181,696
-2,198,780
-30% -$248M 0.16% 144
2017
Q3
$1.08B Buy
7,380,476
+357,084
+5% +$48.6M 0.33% 55
2017
Q2
$912M Sell
7,023,392
-505,942
-7% -$62M 0.29% 68
2017
Q1
$937M Sell
7,529,334
-233,604
-3% -$28M 0.3% 61
2016
Q4
$899M Sell
7,762,938
-30,509
-0.4% -$3.4M 0.32% 57
2016
Q3
$815M Buy
7,793,447
+1,013,226
+15% +$110M 0.3% 63
2016
Q2
$669M Buy
6,780,221
+6,255
+0.1% +$647K 0.26% 83
2016
Q1
$678M Sell
6,773,966
-1,515,261
-18% -$156M 0.27% 77
2015
Q4
$993M Sell
8,289,227
-604,111
-7% -$69.9M 0.39% 44
2015
Q3
$962M Buy
8,893,338
+819,600
+10% +$102M 0.4% 38
2015
Q2
$934M Sell
8,073,738
-560,376
-6% -$64.1M 0.36% 42
2015
Q1
$995M Sell
8,634,114
-886,247
-9% -$106M 0.39% 35
2014
Q4
$1.06B Sell
9,520,361
-462,737
-5% -$48.8M 0.42% 33
2014
Q3
$945M Sell
9,983,098
-492,168
-5% -$44.4M 0.4% 36
2014
Q2
$900M Buy
10,475,266
+52,694
+0.5% +$4.01M 0.37% 39
2014
Q1
$727M Sell
10,422,572
-1,788,988
-15% -$142M 0.31% 58
2013
Q4
$1.03B Sell
12,211,560
-210,412
-2% -$16.6M 0.45% 31
2013
Q3
$957M Buy
12,421,972
+2,231,354
+22% +$156M 0.46% 32
2013
Q2
$596M Buy
+10,190,618
New +$613M 0.31% 60

Other funds holding CELG

Wells Fargo's CELG Position: Q4 2019 in Review

Wells Fargo sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,143,828 shares — an estimated $213M sold.

Wells Fargo first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.08B in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Wells Fargo reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Wells Fargo sold 2,143,828 Celgene Corp shares in Q4 2019, an estimated $213M.
  • Wells Fargo first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Wells Fargo's Celgene Corp position peaked at $1.08B in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Wells Fargo's 13F filing for Q4 2019, filed 14 Feb 2020.